Drug delivery specialist Aptar Pharma has announced a strategic three-year research collaboration with Macquarie University in Australia, aimed at optimizing…
Read More
Crossroads in the Global Bio-Supply Chain: China Emerges as a Biologic API Manufacturing Hub Amid US Onshoring Push
A growing number of FDA-approved innovators and biosimilars are being manufactured at China-based facilities as biopharma takes interest in the…
Read More
Evaluating ERS 2026 Insights on Biologic Therapies for Obesity-Driven Asthma Phenotypes
The intersection of metabolic disease and respiratory medicine has emerged as one of the most critical frontiers in modern clinical…
Read More
NICE Recommends Nucala for Severe Asthma and COPD, Expanding Access to Advanced Biologic Therapy in the UK
In a significant development for respiratory healthcare in the United Kingdom, the National Institute for Health and Care Excellence (NICE)…
Read More
